ADAMTS13 and thrombotic thrombocytopenic purpura: We retrospectively analyzed patients who were admitted to the intensive care unit (ICU) of the emergency and critical care center and assumed to have secondary TTP based on ADAMTS13 activity measurements, and also investigated the efficacy of the administration of rTM.